GenScript Biotech Reports Robust Growth in 2024
GenScript Biotech sees 43.5% revenue rise, expanding global reach and strengthening pipeline.
- Latest
- Trending
GenScript Biotech sees 43.5% revenue rise, expanding global reach and strengthening pipeline.
Legend Biotech reports better-than-expected quarterly earnings, $0.49 EPS above estimates, with significant revenue growth.
Experience Ligand Pharmaceuticals Incorporated's financial report and stock price prediction in the healthcare sector. Discover their strategic growth trajectory.
Lazard Asset Management and Coppell Advisory Solutions both acquired stakes in Legend Biotech. The company's stock performance had a low ...
Regeneron Pharmaceuticals, a leading biopharmaceutical company, is gaining recognition for its innovative approach and strong financial performance. With a diverse ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.